This article discusses how Cyto-Mine ® can be used to screen complex populations of primary B cells and hybridomas by employing a miniaturized, high-throughput, homogeneous secretion assay for the ...

A unique method to screen large-scale libraries for industrially useful bacterial strains was recently developed by Tokyo Tech researchers. The simple approach combines biosensors and microfluidics to ...

The downstream processing of virus particles, vesicles, RNAs, plasmids and other forms of DNA, contains multiple interdependent steps, each requiring optimization for best results. This webinar will ...

For decades, antibodies have been one of the crown jewels of modern medicine—powerful molecules that can neutralize viruses, tame autoimmune diseases, and revolutionize cancer care. Yet despite their ...

Decades ago the pharmaceutical industry recognised that sequential experimentation could not keep pace with the scale of its ...

Developing new pharmaceuticals is a complex and costly process that requires innovation and efficiency. High-throughput immunoassays (HTIs) are an emerging technology poised to accelerate the drug ...

A review maps high throughput strategies that link automation, microfluidics, and barcoding into a unified pipeline, enabling faster, more predictive lipid nanoparticle development for genetic ...

The electrical properties of cancer cells can provide information on their cancer type, state, and drug resistance. However, conventional platforms to measure these properties are complex and can only ...

MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the development of an innovative high-precision, high-throughput reconfigurable simulation technology, aimed at providing ...

Twice a year, influenza experts engage in a critically important forecasting bet: pick three to four vaccine strains now that will match the flu viruses people will face in 8-12 months. The strains ...